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Preface
Serologic tests to detect the presence of antibodies to the human immunodeficiency virus 
(HIV) in individuals play an increasingly important role in the efforts to address the global 
AIDS epidemic. With the exponential growth of programs for prevention of mother to child 
transmission, patient care and therapy, and with increasing emphasis on prevention of 
HIV infection and on blood safety, these tests will be an essential tool for diagnosis. It is 
estimated that 100 million people will have to be tested annually to meet the objectives of 
recent major HIV/AIDS initiatives. Some of this testing will be performed using the standard 
enzyme immunoassay assay (EIA) technology, but in many situations, rapid tests for HIV 
will be the most efficient, and perhaps the only feasible, way to provide information about 
HIV status.
Accuracy and reliability of diagnostic/laboratory testing will be critical to the success of 
HIV/AIDS programs. In order to ensure this reliability and reduce errors to a minimum, 
a quality system that addresses all aspects of the testing is essential. The quality system is 
important in any laboratory or testing site, and applies to all testing and activities, including 
simple-to-perform tests. In sites conducting only HIV rapid tests, it is also essential to have 
in place all the elements of a quality system.
The rapid, simple HIV tests that are addressed in this document are single-use, disposable 
devices that may be used to directly test whole blood specimens, serum, plasma, and/or 
oral fluids. These single-use devices present unique challenges – testing is often performed 
by persons without formal laboratory training, there may be no residual specimen that can 
be checked or re-tested, conventional quality control methods cannot be used, and there 
are special problems associated with efforts to provide conventional proficiency testing. 
The purpose of this document is to establish guidelines for applying quality system essentials 
to HIV rapid testing. It is intended to provide assistance to all persons involved in policy 
development, planning, and implementation of HIV rapid testing. The document should 
be useful to government health officials, those responsible for HIV/AIDS programs and 
for managing voluntary testing and counseling sites. It also provides information useful 
for testing personnel, both trained laboratory technologists and those with no laboratory 
training.
As HIV rapid testing is initiated and/or expanded in large numbers of testing sites, it will 
be very important to implement these guidelines, including the important monitoring 
processes, to assure quality and reliability of test results.
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Background
All laboratory testing, including rapid/simple testing for HIV, consists of a series of processes 
and procedures that must be carried out correctly in order to obtain accurate results. An 
approach that monitors all parts of the testing system is needed to ensure the quality of the 
overall process, to detect and reduce errors, to improve consistency between testing sites, 
and to help contain costs. This approach to laboratory quality, called a quality system, is 
defined as the organizational structure, resources, processes, and procedures needed to 
implement quality management of the laboratory or testing site. The quality system includes 
policies, quality assurance, quality control, and quality improvement, and in this document 
is divided into twelve essential elements as described in the Clinical and Laboratory 
Standards Institute (CLSI) document HS1-A, “A Quality System Model for Health Care.”
The performance of HIV rapid testing presents special challenges when undertaking measures 
to improve test reliability and accuracy. These need to be considered when developing a 
plan for implementation of a quality system.
In many instances, HIV rapid testing will be conducted by health care professionals 
who do not have specific laboratory experience, or by lay counselors with no 
formal health care training. The training program for these non-laboratory staff 
members must provide all needed laboratory skills, including specimen collection 
and laboratory safety. Sufficient time for practical hands-on work, as well as some 
measure of competency on completion of the training, will be very important.
Quality control traditionally includes testing specimens of a known value using 
the same reagents and equipment that are used for the specimens being measured. 
Since rapid/simple HIV test kits are single-use devices, this approach is not possible. 
Quality control specimens must therefore be used in a manner that monitors the 
correct performance of the test by the operator and the ability of the test kits to 
work properly. While it is not possible to test each kit, quality control specimens 
can be used to detect damage of an entire batch or lot number of kits by improper 
storage or handling, or through manufacturing defects. The recommendations in 
these guidelines take these factors into account.
External quality assessment (EQA) for HIV rapid testing has frequently been 
conducted by re-testing a sub-set of the specimens using EIA. Several models for 
this re-testing are in use. Some sites are using a random sampling of 5% or 10% 
of all specimens; others are re-testing all positive specimens and 5% or 10% of 
all negatives. A careful statistical analysis reveals the limitations of this kind of re-
testing except in sites with large numbers of specimens. In addition, the re-testing 
process can present a considerable burden to the reference laboratory charged with 
the responsibility of conducting these tests. These guidelines emphasize on-site 
monitoring as another means of performing external quality assessment.
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QUALITY SYSTEM GUIDELINES 
1.0 Organization and Management
A strong commitment from top-level managers is essential for success of the overall 
quality program. This commitment is important at all levels, and national laboratory 
leaders will need to both provide strong leadership from the national level, and also 
to motivate and help laboratory managers throughout the country to understand the 
system and commit to its success.
1.1 Responsibilities at the national level
1.1.1 Establishing a laboratory quality system
Implementing a quality system requires commitment from the top 
levels of management. The Ministry of Health, including national 
laboratory leaders with appropriate government authority, should:
• Establish a national quality system. This should include
– a national office of quality assurance or quality management
– identification of a national quality officer or manager
– identification of a multisectorial working team, in order to extend 
the quality system to all aspects of testing practices and to avoid 
vertical decisions and assessments
• Extend the quality system to all tiers (central, regional, district, point 
of service) of the laboratory network, and to involve all service 
providers at all levels.
• Extend the quality system to all laboratory testing, including HIV 
serology testing.
1.1.2 Planning for management of HIV rapid tests
There must be an overall, country-wide plan for the management of 
HIV testing, including the roles of HIV rapid tests. The following steps 
will be needed in establishing this plan:
• National policies must be established for the use of HIV rapid tests. 
Issues to be addressed include:
– Use of rapid testing as an alternative to EIA. When and where is 
this appropriate?
– Personnel issues. Who will be allowed to perform HIV rapid 
testing, and what training and certification will be required? 
How will appropriate supervision be provided?
– Legal requirements that might apply to testing. Examples include 
country requirements for existing personnel certification as well 
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o Evaluation of HIV rapid test kits that will be used in the country 
and establishing an algorithm to be used for testing.
o Linkages between EIA or other confirmatory methods and rapid tests.
o Development of a standard operating procedure to be used in all 
testing sites.
o Confidentiality issues.
o Requirement for corrective or remedial action.
• A strategic plan for implementation of HIV rapid testing should be 
developed. This plan will include provision for training of personnel 
and for continuously monitoring and improving the testing process. 
It is important to establish a timeline as well as processes to deal 
with many elements of the quality system. 
• Monitoring processes should be established which can identify problems 
and confirm that the system is working. There must be a plan for solutions 
to the problems, and a record kept of corrective actions taken. 
1.2 Responsibilities at the site where testing occurs
At the laboratory or point-of-care facility such as a voluntary counseling 
and testing center (VCT) there must be provision for oversight of the testing, 
and for ensuring that the necessary staff and supplies are available, and that 
confidential record systems are established and maintained. Steps in this 
process include the following:
• Management of the HIV testing quality system program at each site must 
be assigned to one person; this person may be designated as a quality 
officer. The responsibility should be assigned to someone with authority 
to make and implement decisions, with strong knowledge of HIV testing 
procedures, and with a complete understanding of the quality system 
essentials that need to be addressed. In some settings, one quality officer 
might serve several sites. The quality officer should have a clear channel 
of communication to the Ministry of Health or policy body, as well as with 
all staff who are performing testing, so that any changes in procedure or 
other important information can be shared in a timely fashion.
• A standard operating procedure must be available at each site. This step-
by-step set of instructions that outlines all the processes for conducting the 
testing, including on-site rapid tests, must be accessible to everyone who 
performs tests.
• Local management must ensure that all testing is performed by staff who are 
trained and certified according to the national requirements. The quality 
officer must also have a plan for evaluating the competency of personnel 
performing testing, both initially and on an on-going basis at appropriate 
intervals. If there is no national certification program, local management 
must ensure that staff are trained and are competent to perform HIV rapid 
tests according to these guidelines or national requirements.
• Oversight of the recordkeeping system must be provided. 
• The quality officer should ensure that all other components of the quality 
system are in place before testing is begun at a site. No testing should be 
conducted until the site can be demonstrated to be properly prepared.
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2.0 Personnel
The most important resource in any health care setting is the working staff. It is 
essential that this valuable resource be given the tools needed to perform testing so 
that accurate and reliable test results are obtained. Direct support for the testing staff 
will include initial training for the testing and some method for periodic evaluation 
of each person. This periodic evaluation is conducted to ensure that all protocols, 
including SOPs, are being followed and that testing can still be performed accurately. 
Unlike other laboratory testing, HIV rapid tests will frequently be performed by 
individuals who do not have training in laboratory technology. Therefore, careful 
attention must be given to the training provided, especially for non-laboratory 
personnel.
2.1 Training for persons who will be performing HIV rapid testing 
2.1.1 Initial training programs
Frequently, training of large numbers of staff will be accomplished 
at the time of broad implementation of the testing, for example the 
establishment of a new group of VCTs or the expansion of Prevention 
of Mother to Child Transmission (PMTCT) programs. A standardized 
training program for non-laboratory staff should be developed and 
implemented at all levels of service delivery. Experience in some 
countries suggests that the training program can be conducted over a 
two to five day period, depending on previous education and training 
of those being trained. The training for test performance is most often 
integrated into a program that includes all aspects of counseling and 
testing.
Training should include:
• How to perform the test, including all parts of the process – from 
specimen collection to the reading and interpretation, recording, 
and reporting of results. The appropriate use of external control 
materials must be included.
• A hands-on component, with all participants actually carrying out 
specimen collection and testing procedures.
• How the test is used in the program at the site
• The importance of the quality essentials 
• The importance of biohazard safety procedures, including waste 
disposal.
• An assessment of ability to safely and accurately perform the 
testing.
During the period immediately following training, when new staff 
first begin testing of clients, provision for continuous mentoring is an 
important tool.
Personnel
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Appendix A provides additional details on the content of the core 
curriculum for HIV rapid testing training. Also available are training 
workshop materials, including a participant manual, a trainer’s guide, 
and other tools prepared by WHO and CDC. The use of these materials 
may require a different approach depending on the skill level of the 
audience.
2.1.1.2 On-going plan for training of new staff
The national training plan must make provision for the training 
of new staff as they are hired and added to the workforce. It 
will be critical to the maintenance of quality, reliable testing, 
and may sometimes be a challenge, as the training may have 
to be done for one or two persons. However, all new staff 
should be provided the same training program that is used 
for initial training.
2.2  Additional training needs
2.2.1  Training for those who will provide oversight and monitoring
In many settings, oversight and monitoring of the quality elements for 
HIV rapid testing will be performed by local laboratory staff. When 
choosing personnel to carry out these tasks, consideration should 
be given to good communication skills, an ability to organize and 
carry out jobs, motivation and reliability, and skill in problem solving. 
Additionally, the tasks involved require a set of skills and knowledge 
not always included in the initial laboratory technology training for 
these persons. Provision must be made for training in how to monitor, 
perform on-site evaluations, and provide advice and help to testing 
personnel. 
2.2.2 Training trainers and program staff
Training plans should make provision for training those who will 
have the responsibility of conducting training sessions. Also, it will be 
important to make available training for program staff who may not be 
performing the testing but who need information about how the tests 
are conducted and how they work.
2.3 Certification and early monitoring of performance
The Ministry of Health should develop a program for individual certification 
of non-laboratory staff. An important first step is to establish criteria for 
the successful completion of a standardized training program. This should 
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include a written examination on material presented during the training 
and a demonstration of competency to conduct HIV rapid tests by testing a 
proficiency panel.
In some countries certification is awarded only after successful completion 
of a recognized, standardized training course, followed by another test of 
competence upon assignment to a testing site. This competency check could 
be performed by:
• Before assignment to a new test site, testers perform an internship at 
an established site under direct supervision 
• Testers performing rapid testing at new test site where test 
performance is observed by experienced and trained personnel 
who are temporarily on-site. This direct observation should occur 
for at least 50 specimens, or until the individual has demonstrated 
competency based on site checklist. 
Persons without formal laboratory training who are not certified through an 
official program should not be allowed to perform HIV rapid tests.
In the first few months following training, new staff should receive routine 
mentoring. On-site monitoring visits should be frequent, since these give 
opportunities to help new staff improve skills and recognize problems when 
they occur. New staff will need to know how to seek help from laboratory 
professionals in solving the problems identified. 
2.4 Evaluation of personnel competency on an on-going basis
A method for continuous monitoring of personnel competency needs to be 
developed. Important elements to evaluate for both newly trained personnel 
and for those staff who have been performing testing include:
• Check on ability of the personnel to set up a testing environment 
consistent with that described in the SOP, including temperature and 
storage conditions, labeling and recording instruments, and safety 
considerations.
• Observe test performance to ensure that all steps are performed correctly 
and that the correct result on known specimen(s) can be obtained.
• Provide known samples for analysis by staff who perform testing to ensure 
that the correct result can be obtained.
• Evaluate ability to interpret quality controls and patient/client results, 
including the ability to interpret HIV status based on the established 
testing algorithm.
• Check on ability to properly carry out all record keeping procedures.
Initial and on-going competency evaluation is required for all staff performing 
testing. There should also be a mechanism for correcting any problems or 
deficiencies identified during the monitoring visits. The on-site visit can also 
be used to identify training needs and provide important refresher training.
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3.0  Equipment
One of the great advantages of using rapid, simple technology for HIV testing is 
that little or no equipment is required. However, in some settings the use of whole 
blood or serum may require a centrifuge and pipetting devices. In this case, a plan 
for calibration and maintenance should be developed. If refrigeration is required 
for storing either HIV rapid test reagents or specimens, temperature checks with 
documentation and a maintenance plan must be in place.
Equipm
ent 
Guidelines for Assuring the Accuracy and Reliability of  
HIV Rapid Testing: Applying a Quality System Approach
6 – Equipment
4.0  Purchasing and Inventory
 
Availability of dependable and reliable test kits and supplies is essential. This requires 
a national plan for procurement and distribution, as well as careful management of 
supplies and reagents at the testing site.
4.1 Responsibilities at the national level
• Most countries use a tender process for procurement of reagents and 
supplies for all laboratories and testing sites managed through the Ministry 
of Health. It is important that supplies and reagents be carefully selected 
and that they are ordered in sufficient quantity to last until the next tender. 
• Purchased kits must have an expiration date far enough into the future to 
allow for efficient use and to prevent waste. A policy of “first expired, first 
out” will also help to assure minimum waste.
• The Ministry of Health/national reference laboratory must have some 
means of assessing the quality of the kits, reagents, and supplies as they 
are received by the central purchasing body, to ensure that standards and 
specifications are met. It is recommended that each lot number should be 
checked by the national reference laboratory before distribution.
• A distribution plan that allows these reagents and supplies to reach all 
testing sites within the appropriate time frame and prior to expiration will be 
needed. The plan must take into account emergency or unexpected needs.
4.2  Responsibilities at the testing site
• An inventory record for kits and supplies should be maintained. Each site 
should determine re-order levels for each item in the inventory based on 
workload and usage. This will allow for ordering in a timely manner, so 
that the testing site always has the necessary reagents and supplies and no 
interruption in testing will occur. A method for calculation may be found in 
Appendix B.
• On receipt of new supplies and reagents, the inventory record should 
be updated and all of the new material stored under the appropriate 
environmental conditions. Appendix B provides examples of forms that 
can be used for inventory records.
• To avoid waste, sites should follow the concept of “first expired, first out”. 
Kits that expire earliest must be used before kits with a longer expiration 
date.
Purchasing and Inventory
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5.0  Process Control
Process control refers to the activities and techniques that are carried out to ensure 
that the testing procedures are correctly performed, that the environment is suitable 
for reliable testing, and that the test kit works as expected to produce accurate and 
reliable results. Steps in the testing process follow the path of workflow, and begin 
with tasks done before testing, followed by tasks done during and after testing. 
The path of workflow is frequently described as those steps done before testing 
(pre-analytic), those done while testing (analytic), and the steps that follow testing 
(post-analytic). When using HIV rapid test kits, there are a number of steps in these 
three parts of the path of workflow that are essential in order to assure accurate and 
reliable test results.
5.1  Evaluation of methods
Evaluation of HIV rapid test kits should be performed by the national reference 
laboratory or other appropriate body. In order to assure availability of kits for 
testing, it will be necessary for each country to have checked the validity and 
have approved several HIV rapid test kits for use in the country. The Ministry 
of Health should establish a national policy regarding appropriate tests to 
use and an approved algorithm for testing. A document developed by WHO/
AFRO, CDC, and APHL provides guidelines for this evaluation; Guidelines 
for Appropriate Evaluations of HIV Testing Technologies in Africa. 
5.2  Standard operating procedure
 
A standard operating procedure (SOP) must be developed that provides 
detailed instructions on all aspects of the testing, to include transport of 
specimens, storage and inventory information, test requesting, environmental 
requirements, specimen collection and management, test performance, 
quality control instructions, test interpretation, reporting and recording results, 
appropriate use of the testing algorithm, and any external quality assessment 
requirements. Each testing product will need its own SOP. A written SOP 
should be available at each testing site, and should always be followed when 
conducting tests. A chart showing a simplified version of the procedure steps 
(work instructions) is very useful, and should be provided at the point of 
testing performance. The test site must have written instructions on all policies 
and procedures that need to be followed when conducting tests, including 
such things as personnel training and certification requirements, competency 
checks, confidentiality policies and safety.
The work instructions would lay out steps to be taken during the work process, 
and would include any pre-analytic, analytic, and post-analytic information 
needed, such as the following steps:
Pre-analytic: 1.  Check storage and room temperatures daily.
 2. Check inventory and test kit lots as needed.
Process C
ontrol
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 3. Receive requests for testing.
 4. Set up test area.
 5. Record all needed data, such as kit lot number, operator  
  identity.
Analytic: 1.  Follow biohazard safety precautions.
 2. Perform external quality control (see discussion under  
  5.3.1) according to instructions.
 3. Correctly identify person to be tested if pre-counseled  
  by someone else.
 4. Collect the specimen, including specimen for EQA if  
  needed.
 5. Perform the test as directed by the manufacturer.
 6. Interpret the test results.
Post-analytic: 1.  Re-check patient identifier and report results.
 2.  Clean up and dispose of biohazardous waste. 
 3.  Package and transport EQA re-test specimens to referral  
  laboratory, or appropriately store until next shipment to  
  referral laboratory, if needed.
An example of a standard operating procedure for an HIV rapid test kit is 
shown in Appendix C.
5.3  Quality control
Quality control procedures are essential to ensure that the testing process 
has been carried out properly and that the kit reagents are performing as 
intended.
5.3.1  Definitions of quality control materials
For this document the terms internal quality control and external 
quality control will be used as follows:
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Type of quality 
control
Description /Definition
Internal quality control A control is either provided or 
built in to each test kit or device. It 
generally provides information about 
adequacy of quantity of specimen 
and whether the kit is working 
properly.
External quality control Known positive and negative 
specimens or control materials. 
These may be purchased from 
a manufacturer or made locally 
(usually by a reference laboratory). 
These positive and negative 
specimens are used to evaluate the 
accuracy of the test and to check if 
the person doing the test performs it 
correctly.
 
The internal control in most cases is built into the testing device 
and will always be a part of the testing process. In some kits, these 
controls may be provided as a separate material, but will still be used 
with each test. Internal controls usually do not check the entire testing 
process.
External controls cannot be used with each test, but must be tested 
periodically in order to assure that the test kits are accurately detecting 
HIV antibodies.
5.3.2  Frequency of running external quality controls
The Ministry of Health should establish policy for how and when 
external quality control material should be used. This information must 
be provided and described in the standard operating procedure.
Frequency of use of quality control material is dependent on several 
factors. The condition of the kits must be evaluated over time. In areas 
where environmental conditions are sometimes extreme, difficult 
to control, and where transportation can be challenging, it will be 
important to check kits fairly often. Workgroup discussants for this 
document have made recommendations based on experience with 
local problems.
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Run a negative and a positive control (and weakly positive 
when possible) at the following times:
1. At least once weekly, preferably at the beginning of the 
week.
2. When a new operator (a trained staff member who has not 
been doing testing for awhile, or a newly trained operator) is 
performing testing.
3. When beginning use of HIV rapid test kits with a new lot 
number.
4. Whenever a new shipment of test kits is received.
5. If rapid test kits are exposed to environmental conditions that 
fall outside the range needed for stability as defined by the 
manufacturer.
5.3.3  Recording and monitoring quality control results
The national policy should provide guidance on how to record and 
monitor quality control results. Standardized methods of record 
keeping will make it easier to compile data, monitor performance of 
the quality control material, and monitor test performance. Information 
provided to the testing sites should include:
• A standard worksheet that includes spaces for recording of QC 
results.
• A separate register for QC results, to which information will be 
transferred from the worksheet. This allows for quick review of  
QC data.
• A flow chart for corrective action, showing steps to follow when the 
QC results do not read as expected. This should include information 
on how to refer problems back to the reference laboratory.
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When running controls for HIV rapid testing, it is important to use 
both a negative and a positive control. Whenever possible, a weakly 
reactive positive control should be included that has been validated 
to yield weakly reactive results on all HIV rapid test kits used. 
Recommendations
All quality control data should be regularly reviewed by the quality 
officer with responsibility for the testing site.
Examples of forms for recording QC data can be found in Appendix D.
5.3.4  Sources of quality control materials
Quality control materials are available commercially, sometimes from 
the manufacturer of the HIV rapid test kit. They can also be prepared 
within the country, usually by the national reference laboratory. In 
some countries, the capability and capacity for preparing QC materials 
may be present in regional or provincial laboratories. These steps are 
needed for reliable materials to be used in testing sites:
• Materials for QC use should be prepared using a standard protocol. 
Two options for preparation of QC material are presented in 
Appendix E. These include 1) aliquoting and storing known positive 
or negative specimens, and 2) preparation of weakly positive 
controls. In the latter case, the weakly positive controls should be 
evaluated with all nationally approved HIV test kits.
• The reference laboratory should provide information on expiry 
dates for the material.
• The reference laboratory should monitor the performance of the 
material by reviewing data from the testing sites.
• It is recommended that QC materials be distributed with the test 
kits, assuring that each site has sufficient QC material for use with 
the kits. 
5.4  External quality assessment 
Through external quality assessment (EQA), the performance of a testing site 
can be evaluated from outside the laboratory or testing site. Methods for EQA 
include traditional proficiency testing, re-testing of specimens, and careful 
on-site monitoring using a checklist and knowledgeable assessors.
5.4.1  Re-testing of specimens
With this EQA technique, serum or dried blood spots are collected 
from the client at the time of rapid testing. The serum or the dried 
blood spots are tested using EIA, at a reference laboratory, and the 
results of this test, or “re-test,” are compared with that obtained from 
the final HIV rapid test result. A common model in use is the re-testing 
of 5% - 10% of rapid test specimens, randomly selected. 
The ability to perform EIA on dried blood spots (DBS) has made it 
easier to collect specimens for re-testing in areas where personnel 
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who can perform venipuncture are not available, or where reliable 
transport of serum specimens is not available. However, the dried 
blood spots must be carefully collected, dried, and properly stored in 
order to produce reliable results. The EIA testing performed on these 
specimens requires an elution step prior to specimen analysis, thus 
requiring additional time and introducing a new source of error. 
Re-testing of specimens has limitations. In many countries there is 
lack of capacity at the national reference laboratory for re-testing 
the large number of samples and for conducting the needed analysis 
of data. Long delays in completing the re-testing results in delayed 
identification of problems. Appendix F outlines the operational 
issues that need to be considered if a re-testing program is to be 
implemented. Finally, statistical analysis reveals that for low-volume 
sites, a very large percentage of samples would have to be re-tested in 
order to detect errors. The following table summarizes the statistical 
information: 
(Note: The number of specimens tested is independent of time.)
Re-test size (and %) needed to provide 95% confidence of detecting 

































A full discussion of the statistical models is presented in Appendix G. 
Note these statistical models show analysis of site-specific data. 
Aggregate data could be obtained by combining data from several or 
many sites, and could have some usefulness in looking at the overall 
program. However, aggregate data is of no value for evaluating site 
error and for taking corrective action.
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Recommendations
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Recommendations
 
• If on-going re-testing is performed, it must be based upon 
statistical considerations and a recognition that it will only be 
feasible in high-volume test sites
• The outcome of re-testing must be analyzed for effective and 
timely feedback
• in order to determine cost-effectiveness 
• to determine if corrective action can be taken if problems 
are identified
• If errors are not found as a result of re-testing, established sites 
should consider discontinuing re-testing. 
5.4.2  On-site monitoring
EQA can be accomplished by a careful on-site observation of the 
testing processes and procedures, carried out by a knowledgeable 
person or team. A checklist that allows for assessment of all parts 
of the quality system is an important tool for such an on-site visit. 
Appendix H provides information on implementing and conducting 
on-site monitoring, including a sample checklist.
 
• On-site monitoring be given major emphasis in the EQA plan.  
In low-volume sites this may be the only EQA tool that is used.
• On-site monitoring should include all aspects of the quality 
system, including personnel competency and training, 
equipment policies, inventory control, quality control practices, 
records and documents, and facilities and safety.
• If other testing is performed at an HIV rapid testing site, an 
integrated approach to on-site visits should be taken to assess 
all aspects of testing practices 
• The site visit should include observation of testing with specimens 
of known reactivity (proficiency panels).
• When possible, direct observation of interaction with a client 
is useful. Other means of assessing performance of testing 
personnel could include exit interviews with clients and use of 
“mystery clients” (persons with known serostatus who present 
anonymously). 
• A standard checklist must be used for all visits.
• The on-site assessment should occur at least twice yearly in 
established sites, and at least quarterly for new sites or sites with 
new personnel. Frequency should be based on initial finds and 
need for corrective action.
• The on-site visits should be instructional and provide a mentoring 
experience. The experience should not be punitive.
A plan must be established for corrective action related to findings 
during the on-site visit. All problems should be discussed immediately 
with on-site staff, and any needed follow-up activities including 
training should be undertaken in a timely manner.
5.4.3  Proficiency testing 
Traditional proficiency testing is organized and conducted by 
a reference laboratory or center. At regular intervals, a panel of 
specimens with known reactivity is sent to all participants who test 
the specimens and return results to the reference laboratory. The data 
is analyzed and information is provided back to the participant testing 
sites.
Proficiency testing for HIV rapid tests has some limitations. The panel 
of specimens sent to the testing site will not necessarily be tested by 
all staff, so it is not a good measure of individual performance. The 
sample size is small, so the ability to detect errors is impaired. Also, 
preparing and distributing specimens for proficiency testing may be 
burdensome for national reference laboratories. Proficiency testing is 
provided in some locations, and when available it is a useful tool in 
combination with on-site monitoring. 
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6.0  Documents and Records 
Standardized documents and records should be developed at the national level in order 
to assure conformity to national standards and for ease in collecting national data. 
Documents and records must be maintained in such a way that they are always up-to-
date and accurate, readily accessible by laboratory staff, and protected from damage 
and deterioration. Retention times for documents and records should be established. 
Policies should be developed to ensure confidentiality when appropriate. 
6.1  Documents 
6.1.1  Definition 
Documents are the written policies, process descriptions, procedures, 
and any blank forms used in the testing process. Documents developed 
within the quality system include the written standard operating 
procedures, safety policies, personnel policies, and all standard blank 
forms, such as reporting forms.
External documents will also be used and can provide important 
information. Examples of external documents used in an HIV rapid 
testing site could include information from the kit manufacturer, 
references from journals, and any service manuals, such as for 
centrifuges or refrigerators. 
 
6.1.2  Management of documents
Documents should be consistent with national policy, to assure 
uniformity and adequacy of data. All documents need to be managed 
with a tracking system, to assure that all testing sites have current 
information on hand, and that outdated documents are archived and 
ultimately discarded to avoid confusion at the worksite. 
6.2  Records
6.2.1  Definition 
Records result from carrying out processes and procedures within 
the testing process. Examples include worksheets, test result reports, 
labels, temperature and maintenance charts, quality control results 
and charts, EQA activities with results and corrective action, and 
inventory lists. Records are everything used to capture information, 
activities, or results when performing a procedure. They may be kept 
on paper, or electronically using a computer system. Records allow 
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6.2.2  Management of records
Records for HIV testing sites should be standardized and distributed 
from the national level. Worksheets should include at a minimum: 
space for the date and time, client identifiers, name of the person 
performing the test, name and lot number of the kit used, and 
quality control results. A separate quality control chart should be 
maintained to allow for analysis and quick review of quality control 
results. Personnel records on training, competency evaluation, and 
work injury should be kept. All adverse occurrences, including any 
corrective action taken, should be recorded.
Appendix I provides examples of records useful in an HIV rapid 
testing site. 
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7.0 Information Management
Records may be kept either manually or using computer technology. When computer 
systems are available, laboratories are afforded many useful tools for managing 
client data as well as quality control and external quality assessment information. 
For example, a system for tracking specimens (either serum or DBS) collected for 
EQA purposes would make it much easier to manage this aspect of the quality 
system function. If there is country-wide networking, the ability to correlate an 
individual’s clinical data and laboratory results country-wide will be valuable.
When computerized information management systems are available:
• Processes to ensure accuracy and reliability of data, and to protect data from 
damage and loss, must be put in place. 
• Privacy and confidentiality of data must be strictly observed. 
• Staff will need training to develop competency in use of computer tools, 
including use of the specific laboratory system, as well as in word processing, 
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8.0 Occurrence Management
Errors and problems occur in the most carefully conducted and monitored testing 
environments. The purpose of a quality system is to reduce and minimize errors in 
the total testing process. In order to meet this goal, each testing site should have a 
method to detect and resolve problems. It is important to understand root causes 
and to take corrective action.
The following steps are important when adverse incidents, errors, and problems 
occur:
• Investigate the error or problem to determine cause.
• Take action to address the cause of the problem. Corrective actions may result in 
changes in policy or procedures to help ensure that the error will not re-occur.
• Communicate appropriately with all those affected by the error or problem, for 
example, nursing staff, physician, and/or client.
• Keep a record of all circumstances related to the error or problem. Also keep a 
record of corrective action taken and any communications with affected persons. 
This information is useful for those monitoring the testing, for any internal audits, 
and for use if further inquiries from patients or physicians occur.
• The Quality Officer has the responsibility to ensure that this process is followed, 
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9.0 Assessment 
The key to a successful quality system is continuous improvement, and an essential 
component for this process is assessment. Formal assessments may be external, 
performed by persons outside the laboratory or testing site, or they may be conducted 
by staff at the site and be internally managed.
External assessment of testing sites in this model will be conducted as on-site visits, 
and this has been discussed in section 5.42 of this document.
The regular performance of internal quality assessments / audits can yield much 
important information about how well the laboratory or testing site is following its 
quality policies and procedures, and can help to identify problem areas. Information 
on the internal audit process is widely available, and the International Organization 
for Standardization (ISO) describes an internal audit process that is useful in 
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10.0 Process Improvement
Process improvement is part of the continuous effort to look for problems and 
take actions to improve processes. Process improvement is the action of revising a 
process based on information gathered. As used in this model, process improvement 
involves identifying an area to study, then collecting information, evaluating the 
information, and taking corrective action based on the findings. For example, a 
testing site might decide to study its turn-around time; this would require collecting 
data for a period of time, analyzing the data, evaluating whether the turn-around 
time is sufficiently short, and if not, implementing some steps to shorten the time.
All these efforts should be the responsibility of the Quality Officer, who should 
manage all processes related to assessment and process improvement, and who 
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11.0 Service and Satisfaction
For diagnostic testing, customers include both providers who order the tests and 
patients/clients who will eventually receive care based on the results. There should 
be methods to evaluate how well the testing site is serving the needs of these 
customers. Questions to ask: 1) are customers receiving quality service, and 2) are 
program needs being met?
Policies and procedures should be established for responding to all suggestions and 
complaints from customers.
Service and Satisfaction
Guidelines for Assuring the Accuracy and Reliability of  
HIV Rapid Testing: Applying a Quality System Approach
22 – Service and Satisfaction
12.0 Facilities and Safety
12.1  Facilities 
Each site where HIV rapid testing is performed must have physical space that 
is appropriate for the testing. This should include:
• an adequate working surface that can be easily cleaned and maintained
• assurance of an environmental temperature that does not exceed that 
required by the testing kit, 
• refrigeration if needed, 
• facilities for hand washing and cleaning.
12.2  Safety 
Sites must have available, and personnel must follow, procedures to safely 
handle biohazardous material. This includes:
• Instructions on use of gloves, closed footwear, hand washing, handling 
and disposing of sharps, and spill containment and disinfection must be 
provided. 
• Basic safety procedures should be clearly posted or visibly available in the 
laboratory. 
• General policies such as “no eating, drinking, or smoking,” “no 
unauthorized persons in the testing area,” must be enforced. 
• Procedures for safe disposal of all specimens and materials used in testing 
must be available and must be observed at each site. This is essential 
for protecting those performing the tests as well as others who might be 
exposed to discarded materials. All specimens and materials must be 
handled as if they are capable of transmitting an infectious disease. 
• A procedure must be developed for workers to follow if there is accidental 
exposure of staff to biohazardous material. This procedure, as well as a 
list of persons to contact in an emergency, must be readily accessible to 
all staff in the facility. It is recommended that all persons performing HIV 
rapid tests should know their serostatus.
Full safety requirements for testing HIV specimens are very detailed. Any site 
performing testing should have available a complete set of guidelines used in 
the country. Useful references include: ISO, WHO Biosafety guidelines, CDC 
Biosafety Guidelines.
Facilities and Safety
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Useful References
CLSI HS1-A2 “A Quality Management System Model for Health Care”
CLSI GP26-A3 “Application of a Quality Management System Model for 
Laboratory Services”
ISO 19011:2002 - Guidelines for Quality and / or Environmental Management 
System Auditing
Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa
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Appendix A - CDC/WHO Training Program for HIV Rapid Testing 
Implementation Guide:
Establish national policies that will address:
• who will be trained
• who will serve as trainers
• scheduling of training programs to coincide with national program 
implementation
• budget for supplies, kits, printing of training materials, participant 
perdiems, etc.
Training Curriculum:
Module Learning Objectives Content Outline
1 Overview of HIV 
Infection
Duration: 30 min
• Describe the difference 
between HIV infection and 
AIDS
• Discuss the HIV epidemics 
globally, regionally, and 
locally in terms of number of 
people affected
• Define the terms antibody 
and antigen
• Explain how “window period” 
may affect HIV testing 
results
• Describe the progression of 
HIV infection 
• What is HIV?
• What is AIDS?
• The HIV pandemic
• Window period
• Stages of HIV 
infection
2 Integration of HIV 
Rapid Testing in 
HIV Prevention and 
Treatment Programs
Duration: 30 min
• Recognize the need for HIV 
testing and counseling (T&C) 
in HIV prevention programs
• Describe the role of HIV 
rapid testing in supporting 
prevention and counseling 
programs
• State the advantages of 
using HIV rapid tests in 
specific settings (e.g., VCT 
and PMTCT programs)
• Describe the programs/
settings where HIV rapid 
tests are used in your 
country
• Need for expanding 
access to HIV testing
• Testing and 
counseling as an 
integral part of HIV 
prevention, care and 
support services
• Client counseling 
and HIV rapid testing 
are a formidable 
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Module Learning Objectives Content Outline
3 Overview of HIV 
Testing Technologies
Duration: 60 min
• Describe key issues around 
expansion of HIV testing
• Discuss the process for 
developing a national testing 
strategy
• Discuss the spectrum of 
testing technologies for HIV
• Describe WHO/UNAIDS 
Testing Strategies
• Explain HIV Testing 
Algorithms
• Implementing national 
testing strategy
• Challenges with HIV 
testing
• Spectrum of HIV 
diagnostic tests: EIA, 
HIV Rapid Tests, 
Western Blot, Viral 
Load, p24 Antigen, 
CD4
• WHO testing 
strategies
• HIV testing algorithms
4 HIV Testing Strategies 
and Algorithms
Duration: 1 hour
• Explain the benefits of HIV 
rapid tests
• Accurately recognize 
individual test result as 
positive, negative, or invalid
• Describe the approved 
testing algorithm (process) 
• Interpret HIV status using the 
testing algorithm (process)
• Benefits and 
challenges of HIV 
rapid testing 
• Three formats of HIV 
rapid tests
• Reading individual test 
results
• Testing algorithm
• Interpreting HIV status 
5 Assuring the Quality of 
HIV Rapid Testing 
Duration: 1 hour 15 min
• Explain the systems 
approach to lab quality and 
its benefits
• Identify the essential 
elements of a lab quality 
system and how they apply 
to HIV rapid testing
• Recognize key factors that 
may compromise the quality 
of HIV rapid testing
• Describe your responsibilities 
in preventing and detecting 
errors before, during, and 
after testing
• The approach we take 
to achieve quality
• Essential elements of 
a lab quality system 
• Quality assurance 
procedures at the HIV 
rapid testing site
• How you can 
contribute to quality 
before, during, and 
after testing
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Module Learning Objectives Content Outline
6 Safety at the HIV Rapid 
Testing Site
Duration: 45 min
• Adhere to personal health 
and safety practices
• Maintain a clean and 
organized workspace
• Disinfect and dispose of 
infectious materials
• Take appropriate actions 
following accidental 
exposure to potentially 
infectious specimen
• Follow written safety 
procedures and keep proper 
safety records 
• General safety 
practices 
• Work habits 
(personal, work 
space, material)
• Proper disposal of 
sharps and waste
• Disinfection of work 
areas
• Safety documentation
7 Preparation for Testing 
– Supplies and Kits
Duration: 50 min
• List and identify all the 
supplies required for HIV 
rapid testing
• List and identify all the 
components of test kits for 
HIV rapid testing
• Supplies & materials
• Test kits
8 Blood Collection: 
Finger prick
Duration: 2-2.5 hrs
• Explain the preparation tasks 
required for rapid tests
• Put a client at ease while 
collecting blood
• Collect blood from a finger 
prick accurately and 
confidently
• Preparation for testing
• Educating your client
• Performing finger prick




• Perform 3 HIV rapid tests 
according to SOP
• Perform multiple tests 
simultaneously
• Accurately interpret 
individual test results 
• Accurately determine HIV 
status




• Practice session with 
known specimens
• Practice session with 
blinded specimens
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Module Learning Objectives Content Outline
10 Inventory: Managing 
Stocks at the HIV 
Rapid Testing Site
Duration: 1 hour
• Maintain proper records
• Maintain proper level of 
consumables 
• Use first-expiry-first-out 
concept when managing 
stocks
• Inspect delivery of supplies 
before acceptance
• Identify lot numbers and 
expiry dates
• Keep kits and supplies in 
proper storage




• Receipt of 
consumables 
• Storage of 
consumables 
11 Use and Care of 
Equipment at the HIV 
Rapid Testing Site
Duration: 55 min
• Specify your responsibilities 
related to equipment
• Routinely monitor the 
temperatures of refrigerators 
and freezers
• Confirm that auto pipettes 
deliver specified volumes
• Properly use and maintain 
centrifuges
• Rationale for using 
properly maintained 
equipment
• Your responsibilities 
for equipment
• Use and care of 
equipment at the HIV 







• Differentiate between internal 
and external controls
• Use external quality controls 
at designated frequencies
• Analyze common problems 
associated with invalid test 
results
• What is Quality 
Control (QC)?
• Benefits of QC in rapid 
testing




• Quality control records
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Module Learning Objectives Content Outline
13 EQA: On-site 
Evaluation and Re-
testing
Duration: 1 hour 30 min
• Assess operations at test 
site to determine if quality 
requirements are met
• Take corrective actions 
following External Quality 
Assessment (EQA)
• Keep appropriate records 
related to EQA
• Avoid common problems 
associated with EQA 
specimen management







• How to implement 
EQA
14 Blood Collection and 
Handling: DBS
Duration: 1.5 hours
• Collect dried blood spots 
(DBS)
• Package and store DBS in 
a way to maintain specimen 
integrity
• Maintain DBS records
• Distinguish between valid 
and invalid DBS
• Required supplies
• How to collect and dry 
DBS
• How to package and 
store DBS
• Valid and invalid DBS
• Hands-on practice
15 Documents and 
Records
Duration: 30 minutes
• Tell the difference between a 
document and a record
• Explain the rationale for 
maintaining documents and 
records
• Provide examples of 
documents and records kept 
at a test site
• Follow the procedures as 
prescribed in SOPs 
• Describe how to properly 
keep and maintain test site 
documents and records 
• Describe the types of 
information typically not 
found in a manufacturer’s 
product insert
• What are documents 
and records?
Documents
• Why are they 
important?
• What documents 
should you keep?
• Why is it important to 
follow SOPs?
• What is the proper 
way to keep and 
maintain documents?
Records
• Why are they 
important?
• What records should 
you keep?
• What is the proper 
way to keep and 
maintain records?
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Module Learning Objectives Content Outline
16 Professional Ethics
Duration: 45 minutes
• Describe ethical issues 
related to HIV rapid testing
• Explain the importance of 
professional ethics
• Apply ethical conduct to HIV 
rapid testing
• Take appropriate actions to 
maintain client confidentiality 
• What is ethics?
• Why is ethics 
important?
• Who is responsible for 
ethics?
• How is ethics applied 
to HIV rapid testing?
• Maintaining 
confidentiality
• Code of conduct
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Appendix B - Stock Card
Item Name: _____________________________ Unit: ______________________
Manufacturer: __________________________ 
Kit Lot Number: ________________________ Expiration Date: ______________ 







*Balance Lot # Signature
**Minimum Stock =  Maximum lead time in weeks times (x) maximum usage
 Maximum lead time is 2 weeks
 Maximum usage / 3 months = 3 kits
Minimum Stock = 2 x 3 = 6 kits
*Balance – Perform physical inventory count each month. If physical count does not equal balance, consider 
causes for discrepancies, e.g., theft, expired kits
A
ppendix B
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Stock Book
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Appendix C - **Example of a Standard Operating Procedure 
**This SOP has been provided to illustrate the kinds of information that need to be 
captured and followed to ensure accurate performance and interpretation of test 
procedure. The site in which testing is performed may have specific requirements that 
will need to be incorporated in this SOP and other collective documents.
******************************************************************************************
Test Procedure using Uni-Gold HIV Rapid Test Kit
Check the expiry date and use kits within expiry date
Intended Use
The Trinity Biotech Uni-Gold™ HIV test is a single reagent assay for the detection of 
antibodies to human immuno deficiency virus types 1 and 2 in serum, plasma or whole 
blood.
Principle of the Procedure
Synthetic peptides of diagnostic relevance representing the highly immunoreactive 
sections of the envelope proteins of HIV-1 and HIV-2, glycoprotein gp41, gp120 (HIV-
1) and glycoprotein gp36 (HIV-2) respectively are immobilised at the test region of the 
nitrocellulose strip. The peptides are also linked to colloidal gold and impregnated below 
the test region of the device. A narrow band of the nitrocellulose membrane is also 
sensitised as a control region.
During testing one drop of serum, plasma or whole blood is applied to the sample 
port, followed by two drops of wash buffer and allowed to react. Antibodies to any 
immunoglobulin class, specific to the synthetic HIV-1 or HIV-2 peptides, will react with 
the colloidal gold linked antigens. The antibody peptide-colloidal gold complex moves 
chromatographically along the membrane through the test and control regions of the test 
device.
A positive reaction is visualized by a pink/red band in the test region of the device.
A negative reaction occurs in the absence of human immunoglobulin antibodies to HIV 
in the analyzed specimen. Consequently no visually detectable band develops in the test 
region of the device.
Excess conjugate forms a second pink/red band in the control region of the device. The 
appearance of this band indicates completion of the test as well as proper performance of 
the reagents in the device.
A
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Kit contents:
• 20 Test Devices
Each test device contains colloidal gold labelled with synthetic HIV peptides, 
synthetic HIV peptides as test zone and a control line.
• Wash Reagents (4ml)
o Serum/Plasma Wash - Tris buffered wash containing detergent and preservative 
(0.1% sodium azide).
o Whole Blood Wash - Saline wash containing preservative (0.1% sodium azide).
• 20 Disposable Pipettes
• Package Insert
Materials required but not provided with the kit:
• Timer or stopwatch
• Blood collection devices (i.e., lancets, capillary tubes/ test tubes)
Storage and Stability
The Uni-Gold™ HIV test devices can be stored at 2-27°C. No kit components should be 
used after the kit expiry date.
Precautions
• The Trinity Biotech Uni-Gold™ HIV Test is intended for in vitro use.
• Do not use the kit past the expiration date.
• Do not smoke, eat or drink in areas in which specimens are handled.
• Dispose of all specimens, used devices and pipettes as though they are 
capable of transmitting infection. The preferred methods of disposal are by 
autoclaving at 121°C for a minimum of 60 minutes or by incineration.
• All spills should be wiped thoroughly using a suitable disinfectant such as a 
sodium hypochlorite solution.
• Use a separate disposable pipette and device for each specimen tested.
• Sodium azide is a toxic compound and solutions containing same should be 
handled with care. If the wash solution is disposed through the drain it should 
be flushed thoroughly with water.
• Controls where supplied have been certified virus free. As with all screening 
assays, any results should be considered presumptive until confirmatory assays 
have been performed according to the testing algorithm.
Specimen Collection and Storage
Whole blood, serum or plasma may be used.
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Whole Blood: If fingerstick whole blood is used, drops of blood produced should be 
taken up from the finger-tip by the pipette supplied and dropped from the pipette onto the 
device. Blood droplets should not be dropped directly from the fingertip onto the device 
as their size may vary. Whole blood specimens should be used within ten minutes of 
collection for optimum performance.
If a specimen has started to clot, do not remix before testing. In such instances, the 
clear serum should be pipetted off the clotted specimen and used for analysis. If an 
anticoagulant has been used in the blood sample, whole blood can be used directly 
on the device using the pipette supplied. If testing is not to be carried out immediately, 
samples should be stored at 2-8°C for up to three days, or preferably, the sample should 
be centrifuged and the plasma retained for future testing.
Serum or Plasma: Serum or plasma may be kept for seven days at 2-8°C. Samples should 
be frozen for longer storage. Avoid repeated freezing and thawing of samples.
Quality Control
Good Laboratory Practice necessitates the use of control specimens to ensure proper 
device performance at least once daily.
A built in procedural control on the test device indicates that the test is functioning 
correctly. A pink/red band should always appear at the control window.
Internal and External controls should be run daily prior to analyzing patient/client 
specimens. Results should be recorded on the QC log. Patient/Client results are reported 
only if QC results are acceptable.
Test Procedure
1. If any reagent /sample have been refrigerated remove and allow to stand for 20 
minutes to reach room temperature.
2. Remove the required number of test devices from their protective wrappers.
3. Label each test with the appropriate patient identification.
4. Using one of the disposable pipettes supplied, fill with sample (serum/plasma/
whole blood).
5. Holding the pipette over the sample port add 2 drops of sample (approx. 60µl) 
carefully.
6. Add 2 drops (approx. 60µl) of the appropriate wash reagent to sample port.
7. Allow 10 minutes for reaction to occur. The result should be read at the end of the 
10 minute incubation time. Results are stable for at least 20 minutes after addition 
of sample to the device
Guidelines for Assuring the Accuracy and Reliability of 
HIV Rapid Testing: Applying a Quality System Approach
Appendix C – 35
Interpretation of Test Results
• One black line of any intensity only in the control window report as negative/ non-reactive.
• Two black lines of any intensity in both the patient and controlwindow report as 
positive or reactive.
• No black line in control window in control window report as invalid 
Limitations
Uni-Gold™ HIV test procedure and interpretation of results must be followed closely 
when testing for the presence of HIV antibodies in serum, plasma or whole blood.
The Trinity Biotech Uni-Gold™ HIV test is intended for the testing of undiluted samples 
only. Samples should not be diluted before testing.
Immunosuppressed or Immunocompromised individuals infected with HIV-1 or HIV-2 
may not produce antibodies to the virus. 
Testing with any kit designed to detect antibodies may give negative results and would not 
be a reliable test method for such patients.
Infants may receive antibodies from an infected mother or they may not produce 
antibodies in response to an infection. Therefore, it is necessary to exercise great care in 
interpreting their results.
AIDS and ARC are clinical syndromes and their diagnosis can only be established 
clinically. Uni-Gold™ HIV test results alone cannot be used to diagnose AIDS. A negative 
result does not preclude the possibility of exposure to HIV or infection with HIV.
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Appendix D - Quality Control Form
Daily Record of Quality Control Results










Low Pos        Pos
Pos Control
Lot #s







Date Action Taken Initials Reviewed by & Date
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Appendix E - Protocol for Preparing HIV Positive  
Quality Control Materials
PURPOSE This procedure provides instructions for making a supply of HIV positive 
samples at a desired reactivity level to be used as a daily control, or as part 
of a proficiency testing panel. 
EQUIPMENT AND MATERIALS:
 Equipment
• Magnetic Stirrer, Non-Heated
• Single channel Pipettes (0.05 – 20 µl, 50-200 µl) 
• Multi-channel Pipettes (0.5 – 20 µl and 50-300 µl)
• Vacuum Pump
• Tubing for Vacuum Pump
• Water bath or incubator 
• Thermometer
• ELISA equipment, e.g., reader, washer
 Materials
• Unit (Blood Type Group O) of HIV antibody positive serum
• Unit (Blood Type Group O) of HIV antibody negative serum 
• Sterilizing Filters, .22 micron
• Cryogenic vials, polypropylene, 1.0 ml (for storage of aliquots)
• Cryovial storage boxes
• Brain Heart Infusion Broth (ready to use in tubes) or Brain Heart Infusion 
(BHI) powder and materials to prepare tubes of broth.
• Sterile screw cap tubes, 16x125 (for BHI broth, if needed) 
• Non-sterile plastic tubes, polypropylene 12x75 (for serial dilutions)
• Glass Stir-rods
• Pipette tips
• Individually Wrapped Sterile Pipettes (1.0, 5.0, 10.0, 25ml)
• Discard or waste containers
• Disinfectant
• Autoclave bags
• Gloves and labcoats
 
HANDLING CONDITIONS:
1. Units of HIV serum should be stored at 2 -8°C. 
2. Follow good laboratory safety practices when handling all samples 
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OVERVIEW OF PROCESS
 1. Calculate sufficient volume required for one year supply of ready-to-use 
aliquots, and an additional bulk volume for freezing and storing for future 
use, e.g., 250ml of serum will yield 500 aliquots of 0.5 ml.
 2. Obtain HIV positive and HIV negative sera. Consider the National Blood 
Transfusion Service as one potential source of sera. 
 3. Heat inactivate positive sera and negative sera
 4. Filter and Sterilize positive and negative sera 
 5. Titrate HIV positive sera 
 6. Perform HIV ELISA test to select desired titered sample
 7. Prepare bulk volume of selected titer 
 8. Validate results of bulk volume 
 9. Aliquot, label, and store
10. Perform homogeneity and stability testing
11. Maintain data logs and records
STEPWISE PROCEDURE:
Calculate volume required
1. Calculate the total volume of sample required before beginning production to 
ensure that sufficient materials / reagents are available. The volume required may 
depend on a number of factors: 
• How long the pooled serum is needed , e.g., 12 months
• How often the HIV test is performed
• The sample volume required by the test
• The number of participating laboratories in your Proficiency Testing 
Program
• Approximately 10% overage for determining homogeneity and 
stability testing
 Obtain HIV positive and HIV negative sera
2. Obtain a unit of sterile HIV antibody positive and HIV antibody negative 
serum from Type O donors. Note: One unit yields approximately 400 ml of 
serum.
• Both units should be negative for HBsAg and HIV antigen.
• Both units should be non-haemolysed, non-laepemic, and free of 
particulate material.
• The HIV positive unit should have a high HIV antibody titre (6 – 8X 
ELISA test cut-off).
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Heat inactivate HIV positive and negative sera
3. Heat-inactivate the HIV antibody positive and negative units at 62oC for 20 
minutes in a water bath.
• If a water bath is not available, place the unit of serum inside a large 
glass container of water in an incubator set to 75oC for 20 minutes. 
• Place a thermometer in the water and monitor a rise in temperature 
to 62oC. 
• Place the unit of HIV antibody positive serum in the water.
• Continue to monitor the temperature of the water and when it again 
reaches 62oC, time for 20 minutes.
Filter and Sterilize sera
 4.  Using sterile technique, filter the heat-inactivated serum through a .22 micromole 
size sterile filter into a sterile enclosed polypropylene container.
 5. Using sterile pipettes and sterile technique inoculate 3 – 4 tubes of Brain Heart 
Infusion Broth with 100µl of the heat-inactivated, filtered serum and incubate at 
37°C for 7 days. 
 6. Store the remainder of the HIV antibody positive heat-inactivated, filtered serum 
at 2 - 8°C.
 7. Using sterile technique, filter the HIV antibody negative serum through a .22 
micromole size sterile filter into a sterile enclosed container. 
 8. Using sterile pipettes and sterile technique, inoculate 3 – 4 tubes of Brain Heart 
Infusion Broth with 100 µl of the filtered HIV antibody negative serum and 
incubate at 37°C for 7 days. 
 9. Store the remainder of the HIV antibody negative filtered serum at 2 - 8°C.
10. At the end of 7 days, check the broths for turbidity. If no turbidity exists in any 
tubes, begin titration of the HIV antibody positive serum.
Titrate HIV positive sera (Determine desired dilution)
11. A titration is conducted as follows:
Make an initial 10-fold dilution of the HIV antibody positive serum by adding 0.1 
ml of the HIV positive sera, and 0.9 ml of HIV negative serum to tube 1. Pipette 
0.50 ml of HIV antibody negative serum into tubes 2-12. Make 2-fold dilutions in 
tubes 2-12 by mixing and transferring 0.50 ml of from tube 1 to tube 2. Continue 
mixing and transferring 0.50 ml through the last tube, ending with a dilution of 
1:20,480.
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Perform HIV ELISA test to select desired titered sample
12. Perform a HIV1/2 ELISA following the manufacturer’s instruction and your 
standard operating procedure. In accordance with the manufacturer’s 
instructions, include kit positive and negative controls in the test run. Test 
each titrated sample, and the original sample from which dilutions were 
made, in triplicate. 
13. Based on the Sample/Cut-off (S/Co) ratios calculated for the HIV antibody 
positive diluted samples, select dilutions that represent a high titered and a 
low titered sample. Generally, a low titered positive has an S/Co ratio of  
2 – 3 and a high tittered positive has an S/Co ratio of 5 – 6.
14. Plot the S/Co ratio results against the sample dilutions. For example, 
a dilution of 1:40,960 will yield a cut-off value of approximately 3; 
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#1
0.1 ml HIV positive serum
in tube #1
Mix and Transfer 0.5 ml
0.9 ml HIV negative serum
as diluent in tube #1
0.5 ml HIV negative serum
as diluent in tubes #2-12 (last tube) 
#2 #3 #4 #5 #6 #7 #8 #9. . . . #12
Tubes 2-12 is a 1:2 dilution of the previous tube
Prepare Bulk Volume 
15. Choose the appropriate dilutions for high titered and low titered positive samples 
and determine the volume of sample suitable for your purpose. For example, if 
500 ml was needed and the 1:10,240 dilution was selected as the high titered 
sample, add 50 µl of the bulk HIV antibody positive serum to 512 ml of the HIV 
antibody negative serum. Use a sterile container with a lid to contain the dilutions 
for the bulk samples.
16. Add a preservative such as Bronidox (0.5%), to the final diluted serum, e.g. 0.5mls 
to 500mls diluted control. Check the package insert of the assay for which the 
QC/PT sample is to be used, to ensure that the preservative is appropriate and will 
not interfere with the performance of the assay.
17. Place the diluted serum on a magnetic stirrer in a biohazard cabinet and mix for at 
least one hour to ensure a homogenous batch.
Validate results of pooled serum 
18.  Retest using the same HIV 1/2 ELISA assay to validate the results of the diluted 
batches of serum. Compare these results of the batch with the initial EIA results. 
Aliquot, Label, and Store
19. If results of the ELISA test are acceptable, aliquot appropriate (small working) 
volumes, e.g. 0.5-1.0 ml from the HIV antibody high positive and the HIV 
antibody low positive batches into sterile internal threaded, polypropylene vials 
with silicon O-rings in the caps.
20. Store the vials and remaining bulk volume in well labeled containers at -80°C until 
needed. Aliquots stored at 4°C should be discarded after one week. 
Perform homogeneity and stability testing
21. To ensue that the pooled serum has been well mixed and homogenous, randomly 
select approximately 10% of total aliquots. Test these samples, and compare 
results with target S/C ratio. Investigate the variability of the samples by calculating 
the CV for the selected samples. The batch of pooled serum is acceptable if the CV 
of the results is less than 15%. 
22. To validate the stability of the level of reactivity of the pooled serum, place 
aliquots of the sample at -20oC , 4°C, and room temp (15-25°C), Test the samples 
at 7, 14, 21, and 28 days. Review the results obtained at each temperature. The 
batch of pooled serum is considered stable if the S/Co ratio is falls within ± 2 
standard deviations of the original results. 
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Appendix F - External Quality Assessment of HIV Rapid Tests: Operational 
Issues for Retesting
If retesting is used as a way to conduct EQA for HIV rapid testing, there are a number of 
aspects to be considered when determining and implementing national (or local) policy.
Collection of samples for retesting
Appendix F provides tables and guidance for selecting the appropriate sample size 
for retesting. The numbers shown in the tables can be applied to any time period, and 
countries will need to select the appropriate period, balancing the need for a reasonable 
retest sample size against how frequently performance needs to be evaluated. For 
example, selecting a time interval of a year may make it feasible for a reference laboratory 
to test the required number of specimens, but may seem unreasonably long for purposes 
of detecting potential performance problems. An interval of three months may, in smaller 
sites, result in a very large number of repeat specimens, but would provide a more 
frequent look at the performance of the site. In summary, the retest sample size required 
for statistical validity and the time period to be used for measurement must be determined 
based upon practicality and sustainability.
Whenever possible the samples collected for retesting should be randomly selected and 
distributed throughout the testing period. This will allow the retesting EQA to be more 
representative of the testing process.
In a site with multiple staff performing testing, it is logistically difficult to attempt to have 
a separate sample for each individual. However, if the retesting is to be representative 
of the performance of the entire site (therefore all persons performing testing), it will be 
important to assure that samples collected for retesting represent as widely as possible the 
entire staff.
Two methods are possible when collecting samples for the retesting:
1. Collection of dried blood spot (DBS). When using whole blood testing with 
a fingerprick, a specimen for DBS can be collected at the same time. A truly 
random sampling would involve collecting DBS on every client and then 
retrospectively selecting a random sample of all DBS specimens. However, this 
may be impractical and requires considerable resources (DBS filter paper, space 
for drying and storing DBS, etc.). Most sites will need to prospectively identify 
those clients who will have a DBS specimen collected, rather than collecting on 
all clients.
2. Venous blood collection. In some areas, a venous specimen is collected 
for testing with an HIV rapid test kit. In this instance, there can be 
retrospective selection of specimens for a random sample. When this 
method is used, all specimens may be aliquoted and stored, and then a 
random selection process used to determine which specimens to retest. 
Alternatively, the selection may be done first, and only the selected 
specimens aliquoted and stored.
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Venous blood collection may also be carried out at sites that perform HIV rapid 
testing with a finger prick, but do not have available (or choose not to use) 
DBS procedures for the retesting. In this case, prospective identification of the 
clients to be tested is required.
Recording information and transporting retesting samples
It is important to maintain patient confidentiality in the retesting process. It is 
recommended that a laboratory register or specimen number be used when sending 
samples from the original testing site to the reference laboratory for retesting.
Distributing the retesting workload for the reference laboratory will help to avoid work 
overload and delays in returning results to the testing site. This will require a preplanned 
schedule so that retest specimens reach the reference laboratory at spaced intervals. 
Frequent transport, a continuous retesting process, and prompt feedback of results will help 
to assure timely monitoring of performance and promopt alerts when problems are detected.
Finally, care must be taken to assure that specimens are transported in such a way that the 
reference or retesting laboratory receives them in good condition.
 
Retesting of samples 
Generally, retesting of samples will be carried out by one or several reference laboratories within 
the country. The reference laboratory, or laboratories, should assure its quality of testing by 
appropriate validation of the EIA technology employed, both for DBS and for venous blood. In 
addition, all laboratories performing this reference testing should participate in EQA for HIV testing.
Following retesting, an approach is needed for investigating discrepancies between the 
original rapid testing and the re-test by EIA. Errors or differences in results may occur 
for a variety of reasons. Operator error in test performance is one cause of discrepancy, 
requiring additional quality assurance and training at the site. A common source of error 
is a transcription mistake at some point in the process. Errors may be produced if the 
samples for re-testing are improperly stored and/or transported. Very slight differences are 
also observed between rapid tests and EIA tests, with neither being more accurate than the 
other. All discrepancies should require investigation. A policy must be developed for how 
to resolve discrepancies, and an acceptable level of discrepancy must be determined. 
Reporting and corrective action
The results of the retesting should be reported to the original testing site and to the 
designated quality officer where applicable. The testing site and its quality officer should 
evaluate all results received from retesting, and take appropriate corrective action when 
performance goals are not met.
 In most countries, the Ministry of Health will also be a recipient of information on the 
results of retesting. The results should be collected systematically and used to 
evaluate testing performance on a national basis, as well as to initiate appropriate 
corrective action when needed.
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Appendix G - External Quality Assessment of HIV Rapid Tests: Statistical 
Models for Re-testing 
Re-testing of samples has been used for monitoring HIV rapid testing in lieu of 
conventional EQA/PT, which often is not available for laboratories and testing sites. This 
document looks at the statistics that apply to this re-testing, and provides information that 
will be useful in determining appropriate models for EQA re-testing. 
 
Current Situation
Currently there are a variety of re-testing EQA schemes in place in various countries. 
Examples include:
1.  Re-testing 5% of all samples and the 1st 40 samples tested by each technician that runs 
tests.
2. Re-resting 10% of all samples.
3. Re-testing all positives and varying percentage of the negatives.
Other considerations are as follows:
• In all cases retesting is with a confirmatory EIA method.
• Current re-testing schemes do not account for numbers of samples tested at each 
site. This volume can be highly variable; from 50 to 1000 tests performed per 
month, or 500 to 10,000 per year.
• Current national rates of HIV prevalence vary from low to very high. In a 
particular site, the rate of positivity may be much higher (or lower) than the 
national prevalence. Rate of positivity in testing sites is highly variable.
• Data on agreement between rapid HIV methods is becoming more available as 
national HIV rapid test evaluations are taking place. Algorithms used require 
confirmation of all positive tests by at least one different method and many 
negatives also have to be negative on two kits (in some countries initial negatives 
are not confirmed). In cases where the first two results do not agree, a third kit 
is used and this is considered confirmatory (several variations exist, but this is 
sufficient for the purposes of this discussion).
• The sample for re-testing must be obtained at the time of initial testing. 
• Errors (disagreement with EIA) can occur for a variety of reasons, including
o use of outdated kits
o improper storage of kits
o lack of technical competence
o clerical error
o insensitivity of the kit
• We do not have (for use in this document) information on current agreement 
rates for re-tested samples. It would be very useful to know the distribution by 
agreement on positive and negative samples, the agreement rates at different sites, 
or the agreement rate for new technicians, in addition to the overall agreement 
rates that are being found.
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Objectives:
The model needs to consider the following variables:
• True error rate (unknown)
• Positivity rate
• Population size (number of cases per study period)
• Probability of detection of errors 
• Number of re-tested cases, or the proportion of cases to re-test
• Decision rule: act on a single discrepancy or multiple discrepancies?
The recommended re-testing scheme should achieve the following objectives:
• Provide a stated level of confidence that low error rates will be detected. 
• Be independent of positivity rate. 
• Accommodate different numbers of tests performed in the time period (50-10000).
• Assume that even a single disagreement will lead to investigation.
• Assume re-testing (EIA) is performed without error.
Model Assumptions:
The model presented below could be applied equally to samples that are positive and 
negative on initial testing, or could be used on all tests no matter what the initial result is. 
The recommended number of samples could be drawn independently from patients that 
are initially diagnosed as positive and from those that are initially diagnosed as negative, 
or could be chosen randomly from all patients. In some instances it would be difficult to 
base re-testing on the initial result, so the easiest re-testing scheme would come from a 
random sample of all patients.
The model assumes that any discrepant result is an action signal. That is, whatever the 
actions are for “suspect” results from test sites, these actions would be initiated on the 
discovery of a single discrepant result, no matter what the sample size or positivity rate. 
The suggested model eliminates the need to consider rate of HIV positivity, but there 
remain four important dimensions to the recommendations:
• Population size 
• Sample size
• True error rate
• Confidence level
Positivity rate would not affect the estimates in the following tables and figures, but it 
would affect the “power” of the procedure (ability to detect errors) if there are different 
probabilities for false negatives and false positives. The positivity rate and the clinical 
impact of false positives and false negatives could lead to different re-testing procedures 
for positives and negatives.
Guidelines for Assuring the Accuracy and Reliability of  
HIV Rapid Testing: Applying a Quality System Approach
46 – Appendix G
Model:
The Hypergeometric distribution can be used to predict the probabilities of detection for 
any given sample size. For this model, 
• Eight different sizes of tests were checked (this could be numbers of negatives or 
positives, or both): 50, 100, 200, 500, 1000, 3000, 5000, and 10000.
• Three different possible error rates were investigated: 1%, 3%, and 5%.
• Three levels of confidence were checked: 90%, 95%, and 99%.
• Three different re-testing rates were checked: 5%, 10%, and 20%.
• For small samples and low error rates it was necessary to assume at least 1 error; 
for example, 50 samples with 1% error rate was assumed to have 1 error, and a 
5% sample produces 3 cases. This can distort the percentages in the tables.
The model was applied in three different ways to answer three questions:
1) For given numbers of cases and given error rates, what sample size is needed to 
provide a stated confidence of having at least 1 discrepant result? The numbers 
can then be converted to percentages of the number of cases (Table 1a-c)
2) For given numbers of cases, given re-testing rates and given error rates, what is the 
probability of observing at least one discrepant result? This can also be called the 
Power of the re-testing and decision rule.(Table 2a-c)
3) For given numbers of cases and given re-testing rates, what is the lowest  
error rate that can be detected with a stated confidence? This is the upper 
limit of the Confidence Interval for the error rate (the lower limit is zero) 
(Table 3a-c)
TABLE 1a: Re-test size (and %) needed to provide 90% confidence of detecting at least 
one discrepant result, when the underlying error rate is 1%, 3%, or 5%E
Number 1%E 3%E 5%E
50 45 (90%) 34 (68%) 27 (54%)
100 90 (90%) 54 (54%) 37 (37%)
200 137 (64%) 63 (32%) 41 (21%)
500 184 (37%) 71 (14%) 43 (8.6%)
1000 205 (21%) 73 (7.3%) 44 (4.4%)
3000 221 (7.4%) 75 (2.5%) 45 (1.5%)
5000 224 (4.5%) 76 (1.5%) 46 (.92%)
10000 227 (2.3%) 77 (0.77%) 47 (0.47%)
Example: If there are approximately 1000 cases in the time period, and 90% confidence is 
acceptable for detecting 5% errors, then a 4.4% re-test will suffice (44 samples)
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TABLE 1b: Re-test size (and %) needed to provide 95% confidence of detecting at least 
one discrepant result, when the underlying error rate is 1%, 3%, or 5%E
Number 1%E 3%E 5%E
50 48 (96%) 39 (78%) 31 (62%)
100 95 (95%) 63 (63%) 45 (45%)
200 155 (78%) 78 (39%) 51 (26%)
500 225 (45%) 90 (18%) 56 (11%)
1000 258 (26%) 94 (9.4%) 57 (5.7%)
3000 284 (9.5%) 97 (3.2%) 58 (1.9%)
5000 290 (5.8%) 98 (2.0%) 59 (1.2%)
10000 294 (2.9%) 99 (1.0%) 60 (0.60%)
Example: If there are 200 cases and the objective is to have 95% confidence in detecting an error 
rate of 3% or more, then the number of re-tested cases would be 78, or 39% of all cases.  
TABLE 1c: Re-test size (and %) needed to provide 99%confidence of detecting at least 
one discrepant result, when the underlying error rate is 1%, 3%, or 5%E
Number 1%E 3%E 5%E
50 50 (100%) 45 (90%) 39 (78%)
100 99 (99%) 78 (78%) 59 (59%)
200 180 (90%) 106 (53%) 73 (37%)
500 300 (60%) 131 (26%) 83 (17%)
1000 368 (37%) 141 (14%) 86 (8.6%)
3000 425 (14%) 148 (4.9%) 88 (2.9%)
5000 438 (8.8%) 149 (3.0%) 89 (1.8%)
10000 448 (4.5%) 150 (1.5%) 90 (0.90%)
Example: If it is desired to have 99% confidence that an error rate of 1% or more can be detected, 
in a situation with 50 (or fewer) cases, then 100% of results need to be re-tested. 
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TABLE 2a: Probability of obtaining at least one discrepant result with re-testing rates of 
5% with error rates of  1%, 3%, and 5%E
Number 1%E 3%E 5%E
50 .06 .12 .17
100 .05 .14 .23
200 .10 .27 .41
500 .23 .54 .73
1000 .40 .79 .93
3000 .79 .991 1.0
5000 .92 1.0 1.0
10000 .994 1.0 1.0
Example: If there are 5000 cases and a 1% error rate (50 errors), then if 5% of cases are re-tested 
(250 cases) there is a .92 probability of selecting at least one of the errors (power).  If there are 
1000 cases (50 re-test cases), there is a .93 chance of detecting 5% errors.
TABLE 2b: Probability of obtaining at least one discrepant result with re-testing rates of 
10% with error rates of  1%, 3%, and 5%E
Number 1%E 3%E 5%E
50 .10 .19 .28
100 .10 .27 .42
200 .19 .47 .66
500 .41 .80 .93
1000 .65 .96 .996
3000 .96 1.0 1.0
5000 .995 1.0 1.0
10000 1.0 1.0 1.0
 
Example: If there are 1000 cases, an error rate of 3% and a re-test rate of 10%, then there is a 
probability of .96 that at least one result will be discrepant.
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TABLE 2c: Probability of obtaining at least one discrepant result with re-testing rates of 
20% with error rates of 1%, 3%, and 5%E
Number 1%E 3%E 5%E
50 .20 .36 .50
100 .20 .49 .68
200 .36 .74 .90
500 .67 .97 .997
1000 .89 .999 1.0
3000 .999 1.0 1.0
5000 1.0 1.0 1.0
10000 1.0 1.0 1.0
Example: If there are 500 cases and a 20% re-sampling (100 re-sample cases), then there is a .67 
probability of having at least one failure in the sample when the error rate is 1%. 
TABLE 3a: Lowest error rate that can be detected with 90% confidence with the stated 
re-testing rates (%ReT) and given number of cases
Number 5%ReT 10%ReT 20%ReT
50 54% 36% 20%
100 37% 20% 10%
200 21% 11% 5.5%
500 8.6% 4.4% 2.2%
1000 4.4% 2.2% 1.1%
3000 1.5% 0.73% <.5%
5000 0.90% <.5% <.5%
10000 <.5% <.5% <.5%
Example: With 3000 cases, it would require 10% re-testing (300 re-test cases) to detect a 1% error 
rate (table entry 0.73%), with 90% confidence. If no errors are found, the 90% confidence interval 
for the error rate is (0 to 0.73)
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TABLE 3b: Lowest error rate that can be detected with 95% confidence with the stated 
re-testing rates (%ReT) and given number of cases
Number 5%ReT 10%ReT 20%ReT
50 62% 44% 24%
100 45% 25% 13%
200 26% 14% 6.5%
500 11% 5.6% 2.8%
1000 5.7% 2.9% 1.4%
3000 1.9% 0.97% <.5%
5000 1.2% 0.58% <.5%
10000 0.58% <.5% <.5%
Example: If 10% of 50 slides are re-tested (5 re-test cases), and no errors are found in the sample, 
then the 95% confidence interval for the error rate is: (0 to .44).
TABLE 3c: Lowest error rate that can be detected with 99% confidence with the stated 
re-testing rates (%ReT) and given number of cases
Number 5%ReT 10%ReT 20%ReT
50 90% 78% 34%
100 59% 36% 19%
200 37% 20% 10%
500 17% 8.4% 4.2%
1000 8.6% 4.3% 2.1%
3000 3.0% 1.4% 0.70%
5000 1.8% 0.88% <.5%
10000 0.90% <.5% <.5%
Example: With a 20% re-test rate and 200 slides in the population (40 cases selected), the error 
rate has to be at least 10% (20 errors), if we are to have 99% chance of including at least one of 
the errors in the re-tested cases. If no errors are found in the re-test cases, the 99% confidence 
interval for error is (0 to .10).
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Observations:
1.  The estimates above can be applied to any subset of testing situations, or any 
combined group, including all tests for a year or all tests with a specific kit. That is, the 
numbers in Tables 1-3 can be used to estimate sample sizes needed to assure levels of 
performance of specific testing centers, technicians, or kits. 
2.  Traditional proficiency testing (PT) and re-testing are both useful EQA methods; they 
serve similar purposes in some ways, but differ in others in their ability to detect errors 
and in the services they provide. Both systems:
• Monitor performance to detect systematic errors.
• Motivate laboratory and technician to pay attention to quality.
• Assure responsible oversight.
They differ in that:
• Re-testing provides more samples than PT and therefore is more sensitive to errors. 
Since error rates of concern are expected to be <5%, large samples are required to 
detect errors.
• PT provides controlled samples and routine interlaboratory communications, with 
manageable operation.
3.  Current field data or re-test data should be mined for additional information, such as 
agreement between kits and the numbers of “tie-breakers” required by a technician or 
a facility. These could be important quality indicators. For example, there should be 
routine recording of all tiebreaker cases, including kit names (and lots) and tie-breaker 
result.
4a.  In sites with low numbers of cases (<500), the likelihood of detecting errors is very 
poor without re-testing large percentages. This would apply to programs that require 
re-testing of all positives (low error rate, high power required).
4b. In sites with 500 or more cases there are opportunities for reasonable power for error 
detection, with feasible but large numbers of re-test cases.
4c. In situations with very large numbers of cases (3000 or more), then re-tested cases can 
be limited to a maximum number. For example, 200 to 250 cases seem to provide 
high power for detecting low error rates, so re-testing rates could be set accordingly. 
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Appendix H.  On-site monitoring
Organization and management 
The Ministry of Health must establish an organizational structure to assure that on-site 
monitoring occurs in all locations. This will require a sufficient number of staff who has 
been trained to conduct the monitoring. Persons with laboratory training and experience 
are preferred for monitoring the testing process, but an integrated approach that also looks 
at overall program needs is important; therefore a team approach to involve those with 
program experience will be helpful.
A decentralized scheme using staff from district or primary hospitals will likely be needed 
in order to adequately monitor all testing sites. There should be a plan for national 
evaluation, and a central data collecting point to assess the process.
Visits should be conducted at least twice yearly to established sites with experienced 
personnel. New sites or sites with new staff should be visited at least quarterly. In sites 
with demonstrated problems, the number of visits should be increased in order to provide 
training and technical assistance.
The findings from each site visit should be recorded according to the national policy, and 
the findings should be reviewed and corrective action taken when required.
      
Guidelines for visit
The routine on-site visit to the testing site should be scheduled in advance, so that all 
necessary preparations can be made. It is preferable to have all staff performing testing to 
be at work on the day of the visit. 
             
During the visit, the assessor or team should meet with hospital, clinic, or testing site 
management to explain visit objectives, solicit input, feedback or concerns about HIV 
testing performance.
The visit to the testing site should include the following elements:
• Conduct an initial, brief meeting with staff to explain objectives, review 
schedule
• During the visit, complete all items on the checklist. 
• Observe the testing facilities and look at current inventory of kits.
• Review standard operating procedures, EQA results, algorithm use.
• Observe on-site staff performing rapid HIV testing on client specimens.
• Observe process of recording results on test request forms and log book
• Review internal quality control results (including kit controls and external 
controls, if available)
• Assess turnaround time (estimate from laboratory staff, review of log books)
• Observe on-site staff performing a proficiency panel of specimens (5-10 
specimens)
• Review results with laboratory staff when completed.
• Conduct a closing meeting with laboratory staff and medical officer or health 
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A report and the completed checklist should be submitted to the relevant authorities 
for review and corrective action if needed. When report is finalized, copies should be 
provided to the monitoring officer (quality officer for the site) and to the management of 
the testing site.
The following is a suggested format for a report, as well as an example of a checklist to be 
used during the visit. These should be modified as needed to reflect national policies and 
experience.
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 Yes No Assessor’s  
comments
Organization • Is there a quality policy manual present 
and accessible?
o Does the policy manual address all 
elements of the quality system?
• Does the site have a designated quality 
officer?
• Is the site manager aware of all quality 
system components?
Personnel • Does testing staff possess certificate 
indicating successful participation in 
HIV rapid test training?
• Has the staff been oriented to the 
patient/client flow at the test site?
• Does staff demonstrate 
professionalism?
• Is number of staff adequate for the 
site workload? 
o Approximately how many tests 




• Are standard operating procedures 
for all aspects of the testing process 
written, up-to-date, and accessible to 
staff?
• Is the handwriting legible? 
• Do worksheets include appropriate 
information?
• Are external quality control records 
up-to-date, easily reviewed?  
• Are corrective actions recorded?
• Are results interpreted and recorded 
according to the SOP and site  
protocol?
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• Are kits and reagents stored properly?
• Is staff following “first in, first out” 
method when managing inventory 
stock?
• Is there a policy for re-ordering kits and 
supplies?   
• Is minimum stock on hand? (Look at 
re-order levels) 
• Is the site ever unable to perform 
testing because there are no kits or 
supplies on hand?  
o How frequently does this occur?
• If unable to test, how is this information 
provided to clients?
• Does testing site have adequate space 
for storage of specimens?
Equipment • Is refrigerator clean and organized?
• Are refrigerator temperatures monitored 
and recorded? 
• Are freezer temps monitored and 
recorded, if present?
• If centrifuge is used, are function 
checks routinely performed?
• If non-disposable pipettes are used, are 





• Is there a written procedure for 
collecting, processing and storing 
specimens? 
• Are specimens appropriately labeled 
and packaged for transport to reference 
laboratory?
• Does staff follow universal or standard 
precautions when collecting or handling 
patient/client specimens? 
• Do DBS or other collected specimens 
meet acceptance criteria?
• Observe staff perform rapid test using 
client specimen.  All steps should follow 
SOP.
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• Are both internal and external quality 
control samples analyzed?
o How often?
o What is the source of QC material?
• Are external quality control results 
recorded and reviewed?
• Are appropriate corrective actions 
taken when controls results do not 
produce expected results?
• Is HIV status reported only when 




• Are test results properly maintained 
and accessible?
• Is a computer used in recording 
information and data? If yes, are there 
procedures to assure accuracy?
• Is patient/client confidentiality 
maintained?
o If yes, is there adequate back-up to 
assure integrity of data in case of 
equipment (computer) failure?




• Is there a written policy for investigating 
errors?
• How is communication with affected 
customers handled?
• Are all errors, with any corrective action 
and communication, recorded?
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 Yes No Assessor’s  
comments
Assessment • What EQA method(s) is used? 
• Are results of re-testing submitted to 
testing site in timely manner?
• Are appropriate actions taken when re-
testing results differ from initial results?
• Has the testing site been monitored 
within last 6 month?
• Have corrective actions been taken for 
previously identified problems?
• Are corrective actions taken and 
recorded?
• Are the results of on-site monitoring 
communicated to staff?
• Observe staff perform rapid tests using 
proficiency panel. (record results for 




• Have any projects been undertaken for 
process improvement?  
Service and 
Satisfaction
• Is staff courteous to clients?
• Are there efforts to reassure client and/
or alleviate client’s fear of needle or 
sight of blood?
• When reporting to outside providers, is 
turnaround time appropriate?
• Does the site solicit input and advice 
from clients?
• Are program needs and expectations 
being met?
• Is the testing space adequate in size; 
clean and well organized?
• Is the environment suitable for patient 
testing (e.g. temperature, electrical 
supply)?
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• Is storage space adequate, clean and 
maintained?
• Are gloves available and used 
routinely?
• Are hand washing supplies and 
facilities available in a convenient area?
• Are work areas disinfected?
• Is biohazard waste disposed of safely?
• Does the laboratory have policy and 
procedure for addressing accidental 
exposure to infectious material?
• Are emergency contacts located in 
visible area at test site?
• Is staff aware of policy for post 
exposure prophylaxis?
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Appendix I   - Examples of documents and records useful in an  
HIV rapid testing site
• Example Specimen Transfer Log for Re-testing
• Rapid HIV Test Request Form
Example Specimen Transfer Log for Re-testing
Insert Name of Referring Testing Site, 
Contact Name
Address and Phone Number
Date:_______________________






























†Lab Req = Laboratory Requisition
A
ppendix I
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RAPID HIV TEST REQUEST FORM
Site Code: _______________ VCT Number:____________  Age_________Sex   M/F
Code name of counsellor/person collecting blood 
________________________________________________________ 
Origin of sample (hospital department – please tick)
    Antenatal clinic              General VCT             Counselling Area               Medical Ward
 TB Ward                                          Outpatients                                              Paediatric Ward
Purpose of testing  (reason for test - please circle)
A = Pregnant woman/ANC attendee    B = male partner     C = VCT general client 
D = clinical care/medical diagnosis         E = TB patient             F = Child given 
Nevirapine/other ARV at birth
Laboratory /Test Site Report
Date ______/______/_______                         Lab /Test Site No……………………
RESULTS
FIRST TEST _____________ Lot No._________ Expiry Date_______ 
SECOND TEST _____________ Lot No. _________ Expiry Date_______
REPEAT TEST
1 _________________ Lot No._________ Expiry Date_______
2 _________________ Lot No. _________ Expiry Date_______
TIEBREAKER 
………………   EXPIRY DATE _________________
   LOT NUMBER  _________________
FINAL RESULT __________________
TESTS PERFORMED BY ________________________
    (PRINT NAME AND SIGN)
Client Result Sheet
Site Code: __________VCT Number:________ Lab Test Site no:____________________
Code name of counsellor/person collecting blood ___________________________________
Origin of sample (hospital department – please tick)
Antenatal clinic                   General VCT             Counselling Area              Medical Ward
       
TB Ward                                               Outpatients                                            Paediatric Ward
Result
HIV Antibody Test Result ……………………Signed………………………………
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